We have identified four particular areas of expertise, shown in the diagram below. As at 31 July 2014, the value of the top 20 investments in our portfolio stood at £234.7 million.
A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies
Unique silicon anodes for next generation Lithium-ion batteries with improved energy density and cycle life
3D stent technology intended to improve the biomechanical and blood flow characteristics of vascular stents